semaglutide weight loss bmi Change With Semaglutide in Adolescent Obesity |

Fueled by record demand for Ozempic, Wegovy, and Mounjaro, the companys parent, Sigma Healthcare, reported a 17% rise in sales for the first quarter of fiscal 2026

With the recent announcement that the shortage of Ozempic and Wegovy is officially over, the FDA has declared that compounding pharmacies must stop producing and selling compounded semaglutide by May 22, 2025

Methods SOUL is a multicenter, double-blind, placebo-controlled randomized controlled trial (RCT) evaluating the reduction in MACE associated with oral semaglutide versus placebo in patients with type 2 diabetes (T2D) and cardiovascular (CV) disease

From smaller portions to fewer take-out orders and an increase in protein-rich foods, weight-loss drugs are changing how Canadians eat